Système ClearLLab 10C

Une solution efficace pour l’optimisation de du processus analytique L&L de votre laboratoire

Le système IVD ClearLLab 10C est la seule solution intégrée d'immunophénotypage L&L* homologuée par la FDA et marquée CE, qui offre tous les composants nécessaires des contrôles de qualité, de la préparation des échantillons, des panels d'anticorps, aux logiciels d'analyse et au matériel de formation. Les panels d'anticorps secs pré-mélangés ClearLLab 10C utilisent la technologie DURA Innovations, ce qui élimine le besoin de pipetage des anticorps, améliorant ainsi l'efficacité tout en réduisant le risque d'erreur humaine.

* Pour les lymphomes non hodgkiniens uniquement

Système ClearLLab 10C

En savoir plus sur le système ClearLLab 10C, une solution intégrée d'immunophénotypage

Explore ClearLLab 10C System Models

Documents techniques

Didn't find what you are looking for? For more results click ici.

Content and Resources

Filter by:
Resource Type
Case 18: Acute Myeloid Leukemia This 55-year-old male presents with circulating blasts on peripheral whole blood smear. A bone marrow aspirate sample is submitted for flow cytometric immunophenotyping using ClearLLab 10C Panels.
Case 4: B Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma This 70-year-old male presents with circulating blasts. A peripheral whole blood sample is submitted for flow cytometric immunophenotyping using ClearLLab 10C Panels.
Case 7: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma The 65-year-old male presents with lymphocytosis. A peripheral whole blood sample is submitted for flow cytometric immunophenotyping using ClearLLab 10C Panels.
ClearLLab 10C Panels Casebook Preview This casebook has been designed to assist in the analysis of flow cytometric immunophenotyping data generated using Beckman Coulter’s ClearLLab 10C Panels IVD marked reagent for Leukemia and Lymphoma analysis on the Beckman Coulter Navios and Navios EX flow cytometers.
ClearLLab 10C System Brochure A simple and powerful solution to expedite and standardize your lab’s Leukemia and Lymphoma* workflow. * Non-Hodgkin Lymphoma only